Answers are grounded in this paper and cite their sources.
Background Melanoma is rare as a secondary malignant neoplasm among childhood cancer survivors. Case We report a case of a 12‐year‐old boy who developed malignant melanoma with systemic metastases 17 months after completing treatment for hepatoblastoma. The diagnosis was made unexpectedly based on a bone marrow examination. The patient did not respond to immune checkpoint inhibitor therapy and died 6 weeks after being diagnosed with melanoma. Whole‐exome sequencing to examine 103 genes associated with cancer predisposition did not identify any germ‐line variants. Conclusion This case study provides a unique example of melanoma in a childhood cancer survivor following hepatoblastoma treatment but does not identify any candidate variant to link hepatoblastoma and melanoma.
No takes yet. Share an insight, caveat, or question.
Kanezawa et al. (2024) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: